PALM BEACH, Fla., Sept. 7, 2023FinancialNewsMedia.com News Commentary 

/PRNewswire/ -- The Global cannabis market just continues to keep growing year after year. The increasing legalization of cannabis and rising acceptance of its use for medical purposes are the key factors driving the growth of the market. A report from Statista projected that revenue in the Global Cannabis market is projected to reach US$51.27 Billion in 2023; Revenue is expected to show an annual growth rate (CAGR 2023-2028) of 14.95%, resulting in a market volume of US$102.90 Billion by 2028.  The report said: "The Cannabis market comprises the sale of various products made of cannabis to both private end consumers and healthcare entities in all the countries where these products were legalized. It covers three markets: Recreational Cannabis, Medical Cannabis, and Therapeutic Cannabis. The geographical scope varies depending on the exact cannabis product as not all types of cannabis are legalized in each country. For example, in Germany, the medical and therapeutic use of cannabis is legal, whereas recreational use is not legal.  The Cannabis market can be considered from three different application perspectives, "spiritual purpose," "health condition management," and "wellness management."  The Recreational Cannabis market includes the consumption of cannabis for non-medicinal reasons, such as boosting physical performance, pursuing creative activities, and experiencing spirituality. Recreational Cannabis can be consumed in the form of extracts, dried cannabis, edibles, and beverages."  Active cannabis companies in the markets this week include: Lucy Scientific Discovery Inc. (NASDAQ: LSDI), SNDL Inc. (NASDAQ: SNDL), Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY).